Formal documentation via progress note within 24 hours of initial consult start time
Document within the electronic medical record with every change in CSF regimen
Document at a minimum of every 7 days
Document at consult discontinuation or sign-off
Pharmacist will discontinue filgrastim once ANC is >1500/μL for 2 days or >1000/μL for 3 days, but the consult will remain active for an additional 48 hrs
Pharmacist will sign off the consult if ANC remains >1000/μL for 48 hrs after the filgrastim order is discontinued
Smith TJ, Bohlke K, Lyman GH, et al. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J ClinOncol.2015;33(28):3199-3212.